Related Experiment Video

Updated: Aug 1, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Phosphatidyl choline-mediated inhibition of Streptococcus pneumoniae adherence to type II pneumocytes in vitro

L R Bérubé1, M K Schur, R K Latta

  • 1Institute for Biological Sciences, National Research Council Canada, 100 Sussex Dr., Ottawa, Ontario, K1A 0R6, Canada.

Microbial Pathogenesis
|March 26, 1999
PubMed

Insights

Dimyristoylphosphatidylcholine (DMPC) liposomes effectively inhibit Streptococcus pneumoniae adherence to lung cells. This bacterial binding specificity to DMPC suggests potential therapeutic applications for DMPC-based treatments.

Area of Science:

  • Microbiology
  • Biochemistry
  • Materials Science

Background:

  • Streptococcus pneumoniae adherence to lung cells is a critical step in pneumonia pathogenesis.
  • Understanding bacterial-host cell interactions is key to developing novel antimicrobial strategies.

Purpose of the Study:

  • To investigate the role of dimyristoylphosphatidylcholine (DMPC) in Streptococcus pneumoniae adherence to A549 lung cells.
  • To characterize the specificity and affinity of bacterial binding to DMPC.

Main Methods:

  • Liposome-based inhibition assays using various lipid mixtures.
  • Fluorescence microscopy and binding isotherm analysis with FITC-labelled bacteria.
  • Surface plasmon resonance (SPR) for real-time binding kinetics.

Main Results:

  • DMPC and DMPC-containing liposomes inhibited bacterial adherence by nearly 80%.
  • Specific binding of S. pneumoniae to DMPC-coated silica beads was observed, with a subpopulation of bacteria showing high affinity.
  • SPR confirmed a high, non-reversible affinity between DMPC and S. pneumoniae.
  • Liposome size >200 nm was required for efficient inhibition, suggesting multivalent binding.

Conclusions:

  • DMPC plays a specific role in mediating Streptococcus pneumoniae adherence.
  • The findings highlight the potential of DMPC-based liposomes as a therapeutic strategy to prevent bacterial lung infections.
  • Multivalent interactions are crucial for high-affinity bacterial binding to DMPC liposomes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Synthesis of Phosphatidylcholine in the ER Membrane01:27

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...